SEC Comment Letter for Itamar Medical Ltd. (CIK 0001613170) — Jan 27, 2021
Itamar Medical Ltd. (CIK 0001613170)
Date: Jan. 27, 2021 · CIK: 0001613170 · Accession: 0000000000-21-001027
AI Filing Summary & Sentiment
File numbers found in text: 333-252364
Letter
United States securities and exchange commission logo January 27, 2021 Noa Farkas General Counsel Itamar Medical Ltd. 9 Halamish Street Caesarea 3088900, Israel Re:Itamar Medical Ltd. Registration Statement on Form F-3 Filed January 25, 2021 File No. 333-252364 Dear Ms. Farkas: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Dillon Hagius at 202-551-6001 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Nathan Ajiashvili
Show Raw Text
United States securities and exchange commission logo
January 27, 2021
Noa Farkas
General Counsel
Itamar Medical Ltd.
9 Halamish Street
Caesarea 3088900, Israel
Re:Itamar Medical Ltd.
Registration Statement on Form F-3
Filed January 25, 2021
File No. 333-252364
Dear Ms. Farkas:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Dillon Hagius at 202-551-6001 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Nathan Ajiashvili